Emergent BioSolutions Inc...

NYSE: EBS · Real-Time Price · USD
8.85
0.03 (0.34%)
At close: Aug 15, 2025, 3:59 PM
8.82
-0.28%
After-hours: Aug 15, 2025, 07:40 PM EDT

Emergent BioSolutions Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
140.9M 222.2M 189.3M 293.8M 254.7M 300.4M 276.6M 270.5M 337.9M 165.1M 330.7M 240M 242.7M 307.5M 723.2M 329M 397.5M 343M
Cost of Revenue
n/a 88.5M 118M 129.6M 309.2M 161M 201.8M 176.8M 190.6M 155.1M 219.4M 148.6M 169.8M 155.9M 212.9M 217.5M 227.8M 99.3M
Gross Profit
57.8M 133.7M 60M 164.2M -54.5M 139.4M 74.8M 93.7M 147.3M 10M 111.3M 91.4M 72.9M 151.6M 510.3M 111.5M 169.7M 243.7M
Operating Income
1.6M 49.9M -9.5M 64.5M -159.1M 39.8M -41.9M -242.1M -292.9M -148.1M -58.4M -42M -72M 6.4M 277.4M -34.7M 14.5M 95.4M
Interest Income
n/a n/a n/a n/a n/a n/a 500K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-16.8M 92.7M -27.6M 142.4M -269.8M 12.1M -54.5M -265.9M -250.2M -161.1M -71.2M -63.9M -82.8M -3.8M 267.5M -45.5M 7.2M 85.2M
Net Income
-12M 68M -31.3M 114.8M -283.1M 9M -49.5M -265.9M -261.3M -183M -88M -75.7M -56.4M -3.7M 189.3M -32.7M 4.6M 69.7M
Selling & General & Admin
43.7M 52.4M 60.8M 76.6M 77.3M 84.6M 87.5M 86M 91.4M 100.5M 94.2M 80.2M 81.1M 84.8M 94.2M 82.1M 91.2M 80.9M
Research & Development
12.5M 15.1M 9.1M 13.8M 27.3M 15M 29.2M 15.3M 26M 40.6M 57.6M 39.2M 49.8M 46.4M 83M 49.6M 48.9M 52.5M
Other Expenses
83.1M 16.3M n/a 6.3M n/a n/a n/a -3.4M -3.6M 17M 17.9M 14M -3M -2M -900K -2.4M 1.3M -1.7M
Operating Expenses
139.3M 83.8M 80.8M 99.7M 104.6M 99.6M 116.7M 117.6M 133.5M 158.1M 169.7M 133.4M 144.9M 145.2M 191.2M 146.2M 155.2M 148.3M
Interest Expense
-14.7M 14.7M 14.8M 8.3M 23.6M 24.3M 22.2M 19.7M 28.6M 17.9M 12.8M 8.5M 7.8M 8.2M 9M 8.4M 8.6M 8.5M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 172.3M 198.8M 229.3M 413.8M 260.6M 318.5M 294.4M 324.1M 313.2M 389.1M 282M 314.7M 301.1M 404.1M 363.7M 383M 247.6M
Income Tax Expense
-4.8M 24.7M 3.7M 27.6M 13.3M 3.1M -5M 16.3M 11.1M 21.9M 16.8M 11.8M -26.4M -100K 78.2M -12.8M 2.6M 15.5M
Shares Outstanding (Basic)
54.2M 54.4M 54.2M 53.1M 52.6M 52.2M 51.9M 51.8M 50.7M 50.2M 49.9M 49.8M 49.91M 50.7M 53.2M 53.61M 53.6M 53.3M
Shares Outstanding (Diluted)
54.2M 57.3M 54.2M 55.6M 52.6M 52.2M 51.9M 51.8M 50.7M 50.2M 49.9M 49.9M 50M 50.7M 53.5M 53.7M 54M 54.5M
EPS (Basic)
-0.22 1.25 -0.59 2.16 -5.38 0.17 -0.95 -5.13 -5.15 -3.65 -1.76 -1.52 -1.13 -0.07 3.54 -0.61 0.09 1.31
EPS (Diluted)
-0.22 1.19 -0.59 2.06 -5.38 0.17 -0.95 -5.13 -5.15 -3.65 -1.76 -1.52 -1.13 -0.07 3.50 -0.61 0.09 1.28
EBITDA
1.6M 132.8M 13.2M 177.1M -216.8M 65.2M -1.8M -214M -185.8M -106.2M -15.4M -42M -34.2M 36.7M 305.7M -5.7M 44.6M 123.8M
EBIT
1.6M 107.4M -12.8M 150.7M -246.2M 36.4M -32.8M -246.2M -221.6M -142.7M -58.4M -58.7M -75M 4.4M 275M -37.1M 15.8M 93.7M
Depreciation & Amortization
n/a 25.4M 26M 26.4M 29.4M 28.8M 30.5M 29.1M 32.9M 34.6M 41.2M 32.3M 44.5M 30.9M 30.7M 32.7M 33.2M 28.7M